Camellia Plc
(the "Company")
Director Changes
Camellia Plc announces that Susan Walker, Chief Financial Officer ("CFO") has indicated her intention not to stand for re-election as CFO and director at the forthcoming Annual General Meeting ("AGM") which is expected to be held on 6 June 2024. Susan has made a significant contribution to the Company since her appointment as CFO in 2015 and the Company thanks her for her dedication and exceptional expertise and leadership.
The Board has undertaken an extensive candidate search process to identify a new CFO and is pleased to announce the appointment of Oliver Capon. Oliver is an experienced and commercial CFO with thirty years of experience, initially at Arthur Andersen and subsequently at Shell Plc, where he worked in the
Susan will continue working with Camellia to facilitate a smooth handover until 30 September 2024 and will, as part of her new portfolio, provide advisory support until 31 March 2025. She will remain a Non-Executive Director of certain of the Company's boards, including the Goodricke Group Limited and
Additional Disclosures
In accordance with the AIM Rules, the following information required to be disclosed in relation to the director is set out below. Other than this information, there is no further information required to be disclosed under paragraph (g) of Schedule Two of the AIM Rules.
Full Name: |
Oliver Capon |
Age: |
53 |
Current beneficial shareholding in the Company: |
None |
Current directorships: |
Oleah Consulting Limited |
Previous directorships within the last 5 years: |
Shell Shared Service Centre - Glasgow Limited |
This announcement contains inside information for the purposes of the
Enquiries
Camellia Plc 01622 746655
Simon Turner, Chairman
Byron Coombs, Chief Executive Officer
Panmure Gordon 020 7886 2500
Nominated Adviser and Broker
Emma Earl
Rupert Dearden
H/Advisors Maitland
PR
William Clutterbuck 07785 292617
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.